Category:
API Equipment
Standard:
N;
China GMP
Form: DPI
Strength: 18mcg
Indication: indicated for the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is indicated to reduce exacerbations in COPD patients
This category refers to long-acting muscarinic antagonist (LAMA) powder formulations designed for inhalation therapy. Manufactured under strict pharmaceutical GMP standards, the active ingredient is a dry powder blend optimized for pulmonary delivery systems.